As of June 10, 2025, Fluicell AB (FLUI.ST) reports a Net Margin of -834.37%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Fluicell AB's Net Margin
Over recent years, Fluicell AB's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | -834.37% |
| 2023-12-31 | -795.51% |
| 2022-12-31 | -664.63% |
| 2021-12-31 | -833.70% |
| 2020-12-31 | -379.50% |
This slight downward trend highlights how Fluicell AB manages its overall profitability and cost control over time.
Comparing Fluicell AB's Net Margin to Peers
To better understand Fluicell AB's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Fluicell AB (FLUI.ST) | -834.37% |
| Scope Fluidics SA (SCP.WA) | 49939.69% |
| Sectra AB (SECT B.ST) | 24.83% |
| CellaVision AB (CEVI.ST) | 19.46% |
| NanoRepro AG (NN6.DE) | 18.27% |
| Surgical Science Sweden AB (SUS.ST) | 14.89% |
Compared to its competitors, Fluicell AB's Net Margin is about average compared to peers, reflecting typical industry profitability.